|
Each year, the NBA is required to coordinate and produce, for approval by all Health Ministers, a National Product Price List and National Supply Plan and Budget for blood and blood products. This annual development is a critically important function for the blood sector as a whole and underpins much of the NBA’s work.
Each year, the NBA has introduced more sophisticated demand modelling processes as it improves its knowledge and understanding of the products and clinical environment. The NBA collects data on issued products and reports to jurisdictions against the approved supply plan to continually improve the national supply planning process. Supply planning commences twelve months prior to the next supply year and must be endorsed by the Jurisdictional Blood Committee and Australian Health Ministers to allow continued funding of blood and blood products to health care providers.
In addition to developing the National Supply Plan and Budget, the NBA is also responsible for the intensive management of products in short supply, which although labour intensive, is essential to ensure that there is an adequate supply of products for Australians who require them.

Feedback | Privacy | Copyright | Disclaimer | Contact Us
This page last modified on January 23, 2009Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)
Public Consultation: Imported Plasma & Recombinant Products
Request for Tender
- National Managed Fund Management and Advice Services
Employment Opportunities
- ICT Project Manager
- EL1 Scientist/Writer/Researcher
- EL2 Chief Financial Officer
Blood Supply to Australians Overseas
NBA Newsfeed
Subscribe to RSS
-- What is RSS?